Skip to main content
. 2022 Sep 12;196(2):311–321. doi: 10.1007/s10549-022-06710-4

Table 5.

Effectiveness parameters (FAS) according to post hoc analysis by TFI

Parameter FAS total n = 126 TFI ≤ 6 mos n = 5 TFI > 6 mos n = 120 TFI unknown n = 1
Median PFS [95% CI] mos 18.8 [15.1, 24.2] 12.4 [3.2, NA] 19.4 [15.4, 25.5] NA [NA, NA]
N. of events, n, % 86 (68.3%) 5 (100%) 81 (67.5%) 0 (0.0%)
Median OS [95% CI] mos 55.9 [41.2, NA] 34.1 [3.2, NA] 55.9 [41.2, NA] NA [NA, NA]
N. of events, n, % 46 (36.5%) 2 (40.0%) 44 (36.7%) 0 (0.0%)
ORR rate (%), 95% CI 64.3% [55.6, 72.1] 60.0% [23.1, 88.2] 64.2% [55.3, 72.2] 100.0% [20.7, 100.0]

CI confidence interval, FAS full analysis set, mos months, N number, NA not applicable, ORR overall response rate, OS overall survival, PFS progression-free survival, TFI therapy-free interval